Market Tracker

08/26 9:52am ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

3.88
Delayed Data
As of 9:37am ET
 +0.0918 / +2.42%
Today’s Change
3.34
Today|||52-Week Range
8.79
-43.99%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close3.79
Today’s open3.87
Day’s range3.73 - 3.92
Volume2,261
Average volume (3 months)31,613
Market cap$50.0M
Dividend yield--
Data as of 9:37am ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-49.55%
Earnings growth (this year)+43.37%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+485.21%
P/E ratioNM
Price/Sales6.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVETNexvet Biopharma plc-0.21-4.85%
OCRXOcera Therapeutics I...+0.07+3.10%
RPRXRepros Therapeutics ...+0.01+0.25%
BLRXBioLine RX Ltd+0.01+0.84%
Data as of 9:37am ET, 08/26/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$9.7M
Annual profit (last year)-$15.9M
Net profit margin-163.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Operations Director
Joe Bitterman
Corporate headquarters
San Diego, California

Forecasts